TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON ALFA-2B

被引：0
|
作者：
NIEDERLE, N
KLOKE, O
MAY, D
BECHER, R
OSIEKA, R
SCHMIDT, CG
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1987年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S25
页数：7
相关论文
共 50 条
  • [1] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    NIEDERLE, N
    KLOKE, O
    OSIEKA, R
    WANDL, U
    OPALKA, B
    SCHMIDT, CG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 29 - 35
  • [2] TREATMENT OF PH'-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH RECOMBINANT INTERFERON ALFA-2B (INTRON-A)
    ALIMENA, G
    MORRA, E
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    INVERADI, D
    BERNASCONI, P
    MANCINI, M
    GRIGNANI, F
    BERNASCONI, C
    DIANZANI, F
    MANDELLI, F
    CANCER TREATMENT REVIEWS, 1988, 15 : 21 - 26
  • [3] Interferon alfa-2b and cytarabine in chronic myelogenous leukemia - Reply
    Guilhot, F
    Guilhot, J
    Chastang, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (22): : 1634 - 1635
  • [4] Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
    Guilhot, F
    Chastang, C
    Michallet, M
    Guerci, A
    Harousseau, JL
    Maloisel, F
    Bouabdallah, R
    Guyotat, D
    Cheron, N
    Nicolini, F
    Abgrall, JF
    Tanzer, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04): : 223 - 229
  • [5] EVOLVING MODALITIES OF TREATMENT WITH INTERFERON ALFA-2B FOR PH(1)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    MORRA, E
    ALIMENA, G
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    BERNASCONI, P
    MANCINI, M
    DONTI, E
    MERANTE, S
    DIANZANI, F
    GRIGNANI, F
    BERNASCONI, C
    MANDELLI, F
    EUROPEAN JOURNAL OF CANCER, 1991, 27 : S14 - S17
  • [6] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA
    BERGSAGEL, DE
    HAAS, RH
    MESSNER, HA
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 29 - 34
  • [7] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA
    BERGSAGEL, DE
    HAAS, RH
    MESSNER, HA
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S9 - S17
  • [8] RECOMBINANT INTERFERON ALFA-2B (IFN ALFA-2B) IN CHRONIC MYELOID-LEUKEMIA (CML) - INVIVO AND INVITRO RESULTS
    WANDL, UB
    NIEDERLE, N
    OPALKA, B
    KLOKE, O
    SCHMIDT, CG
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 442 - 442
  • [9] Combination therapy with interferon Alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemia
    Bourantas, KL
    Syrou, M
    Tsiara, S
    Danella, M
    Konstantinides, P
    ACTA HAEMATOLOGICA, 1996, 95 (02) : 117 - 121
  • [10] TREATMENT WITH RECOMBINANT INTERFERON ALFA-2B IN CHILDREN WITH CHRONIC HEPATITIS-C
    HELLER, S
    CERDAN, L
    GONZALEZ, J
    VELASCO, M
    HEPATOLOGY, 1994, 19 (04) : I72 - I72
12345